(Q62110952)

English

Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and Thalidomide

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

UARK 99-016, A Phase II Trial of Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and Thalidomide in Patients With Multiple Myeloma and Poor Hematopoietic Stem Cell Reserve (English)

0 references

medical condition

multiple myeloma

0 references

sponsor

University of Arkansas

0 references

country

United States of America

0 references

start time

March 1998

0 references

number of participants

20

0 references

research intervention

thalidomide

0 references

clinical trial phase

phase II clinical trial

0 references

research site

University of Arkansas

0 references

research subject recruitment status

completed

0 references

study type

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

NCT00083408

0 references

(Q62110952)

Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and Thalidomide

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)